CASC3 and Miyoshi myopathy: As a result, the inhibition of Glu antiporter system Xc-with sulfasalazine could suppress exosome release and its mediated crosstalk between MM cells and BMSCs, hence facilitating the combined therapeutic efficacy of BTZ and sulfasalazine [103].